Data from: Health Canada’s use of accelerated review pathways and therapeutic innovation, 1995-2016: a cohort study
Joel Lexchin
Objectives: This study examines the use of accelerated approval pathways by Health Canada over the period 1995 to 2016 inclusive and the relationship between the use of these pathways and the therapeutic gain offered by new products. Design: Cohort study. Data sources: Therapeutic Products Directorate, Biologics and Genetic Therapies Directorate, Notice of Compliance database, Notice of Compliance with conditions web site, Patented Medicine Prices Review Board, La revue Prescrire, World Health Organization (WHO) Anatomical Therapeutic...
1 citation reported since publication in 2018.
40 views reported since publication in 2018.
These counts follow the
COUNTER Code of Practice,
meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?
2 downloads reported since publication in 2018.
These counts follow the
COUNTER Code of Practice,
meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?